Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Meira, Wendell S. F., Galvão, Lúcia M. C., Gontijo, Eliane D., Machado-Coelho, George L. L., Norris, Karen A., Chiari, Egler
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Parasitology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC344465/
https://ncbi.nlm.nih.gov/pubmed/14766840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.2.707-712.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars